Why one company is focusing on camelid-derived antibodies to tackle dengue.

US-based law and patenting experts offer their thoughts on IP protection in the digital age

Nominations are open now – but only until October 10.

Studying the link between Alzheimer’s risk, estrogen levels, and menopausal status in women

Perrigo’s Opill receives FDA approval following unanimous support from advisory committees

Experts discuss the most promising growth prospects in the cell and gene landscape

What lies ahead for biopharma manufacturers when it comes to downstream analytical tech?

How scientists extracted a treatment for episodic ataxia from traditional Kwakwaka'wakw medicine

The pharma giant’s COVID-19 vaccine saved millions of lives, but the company is quickly falling from grace.

We need non-opioid options for pain relief. Paradigm Biopharmaceuticals discuss their studies into a new option for osteoarthritis patients